Multiagent chemotherapy in relapsing ovarian cancer
- 30 June 1983
- journal article
- research article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 146 (6) , 613-616
- https://doi.org/10.1016/0002-9378(83)91000-1
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Chemotherapy of ovarian cancer directed by the human tumor stem cell assayCancer Chemotherapy and Pharmacology, 1981
- Pharmacologic studies of anticancer drugs with the human tumor stem cell assayCancer Chemotherapy and Pharmacology, 1981
- cis-Platinum-hexamethylmelamine therapy of advanced ovarian cancerGynecologic Oncology, 1981
- IN-VITRO CLONOGENIC ASSAY FOR PREDICTING RESPONSE OF OVARIAN CANCER TO CHEMOTHERAPYThe Lancet, 1980
- COMBINATION CHEMOTHERAPY OF ADVANCED OVARIAN-CANCER WITH HEXAMETHYLMELAMINE, CIS-PLATINUM, AND DOXORUBICIN AFTER FAILURE OF PRIOR THERAPY1980
- Ovarian CancerPublished by American Medical Association (AMA) ,1979
- Quantitation of Differential Sensitivity of Human-Tumor Stem Cells to Anticancer DrugsNew England Journal of Medicine, 1978
- Cis-Diamminedichloroplatinum, Vinblastine, and Bleomycin Combination Chemotherapy in Disseminated Testicular CancerAnnals of Internal Medicine, 1977
- Primary Bioassay of Human Tumor Stem CellsScience, 1977
- Second trial drugs in ovarian cancerGynecologic Oncology, 1977